Yahoo Web Search

Search results

      • David Ames' main research and clinical interests have been detection and management of Alzheimer's disease (AD) and new therapies for AD and the care of the depressed elderly. He has published over 300 papers in peer reviewed journals and edited 21 books. He has led the Australian Imaging Biomarkers and Lifetyle study of Ageing since 2006.
      findanexpert.unimelb.edu.au › profile › 13570-david-ames
  1. David John Ames AO (born 1954) is an Australian psychiatrist and academic. In addition to being Emeritus Professor in the Department of Psychiatry at the University of Melbourne, he is a part-time consultant psychiatrist at a number of hospitals in Melbourne, a professorial fellow with The National Ageing Research Institute and a research ...

  2. People also ask

  3. David Ames' main research and clinical interests have been detection and management of Alzheimer's disease (AD) and new therapies for AD and the care of the depressed elderly. He has published over 300 papers in peer reviewed journals and edited 21 books.

  4. He is a co-author on over 450 papers in peer reviewed journals and co-editor of over 20 books including 4 editions of the reference text Dementia. From 2006-2019 he chaired the Australian Imaging Biomarkers and Lifestyle study of ageing.

  5. David Ames is an experienced old age psychiatrist with particular expertise in the assessment and management of late life cognitive decline and dementia.

  6. From April 2005, David Ames was University of Melbourne Foundation Professor of Psychiatry of Old Age at St George’s Hospital, Kew. Since September 3, 2007 he has been Director of the National Ageing Research Institute and University of Melbourne Foundation Professor of Ageing & Health.

  7. Aug 2, 2024 · David Ames: It's 14 preventable risk factors, and it's dementia as a whole. If we could eliminate these 14 risk factors, in theory we'd make a big reduction in the future incidence of dementia.

  8. David Ames' main research and clinical interests are detection and management of Alzheimer's disease (AD) and new therapies for AD and the care of the depressed elderly. He has published over 130 papers in peer reviewed journals and edited 15 books.